HeartBeam has announced a strategic alliance agreement (SAA) with global tech giant Samsung. The alliance, announced today, builds upon an existing SAA between Samsung and Livmor, whose assets HeartBeam acquired earlier this year. Livmor created the FDA-cleared wearable Halo atrial fibrillation detection system — an FDA-cleared, Samsung-Galaxy-watch-based arrhythmia detection tool. Meanwhile, HeartBeam recently secured a […]
samsung
Samsung, HealthTap partner to bring virtual care to Smart TVs
HealthTap announced a strategic partnership with Samsung to bring virtual healthcare directly to Samsung’s Smart TVs in the U.S. The strategic partnership brings a telehealth solution to Samsung Smart TV users’ fingertips. HealthTap offers access to healthcare via its mobile and desktop applications, with the new capabilities highlighting a step forward for its platform. Palo […]
Samsung unveils new V7 ultrasound system
Samsung today introduced its V7 ultrasound system, having recently picked up FDA 510(k) clearance for commercial use. Danvers, Massachusetts–based Boston Imaging — the U.S. headquarters of Samsung’s digital radiography and ultrasound business — unveiled the platform. It designed the ultrasound system to provide a range of clinical applications, improving the patient and user experience. “There […]
EchoNous partners with Samsung on AI-guided ultrasound
EchoNous announced today that it entered into an alliance with Samsung to run its ultrasound offerings off the Galaxy mobile tablets. Redmond, Washington–based EchoNous develops the Kosmos portable, artificial intelligence (AI)-guided point-of-care ultrasound (POCUS) tool. Under the new partnership, Kosmos will now be able to run on off-the-shelf Samsung Galaxy Tab Active Pro tablets (models […]
Texas power grid struggles a year after cold stopped semiconductor plants
A heatwave in Texas took at least six power plants offline Friday, with high temperatures forecasted to blaze throughout this week. A record cold snap in February 2021 took NXP Semiconductors and Samsung chip fabrication facilities offline for weeks, contributing to a global semicondcutor shortage that is still throttling medical device production. There’s no indication […]
Microsoft CMO: Using the cloud to improve medtech design, manufacturing and care
Dr. David Rhew, Microsoft’s global chief medical officer and VP of healthcare, has been studying how technology can improve health outcomes for nearly three decades. His focus has long been on access to care, quality of care, patient safety, improving experiences for patients and providers, and finding ways to improve the overall efficiency of care. […]
Medtronic wins FDA nod for InterStim sacral neuromod programmer
Medtronic (NYSE:MDT) said today that the FDA approved its InterStim smart programmer, designed to work with the company’s InterStim sacral neurmodulation system intended for tor treating overactive bladder, chronic fecal incontinence and non-obstructive urinary retention. The newly cleared smart programmer is run on a Samsung Electronics (LON:BC94) mobile device and allows clinicians to personalize patient care and manage […]
Samsung’s NeuroLogica, MaxQ AI ink collab distro deal
Samsung Electronics (LON:BC94) subsidiary NeuroLogica said today that it inked a distribution deal with MaxQ AI to integrate its artificial intelligence software with NeuroLogica’s medical imaging tech in the U.S. and EU’s acute care marketplace. Through the deal, NeuroLogica said that it will offer MaxQ’s Accipio IX, part of the AI-company’s FDA-cleared and CE Mark approved […]
Samsung’s NeuroLogica wins $250m US DoD radiology supply contract
Samsung Electronics (LON:BC94) subsidiary NeuroLogica won a $250 million maximum firm-fixed-price contract to supply the US Dept. of Defense with radiology systems, accessories and training, according to a newly posted release. The contract for the Danvers, Mass.-based subsidiary is located in Massachusetts and has a five-year base and an additional five-year option period, according to the […]
HRS 2018 Roundup: Device-related blood clots with Boston Scientific’s Watchman implant
Data from a study of device-related blood clots and the Watchman cardiac implant made by Boston Scientific (NYSE:BSX), presented today at the annual meeting of the Heart Rhythm Society in Boston, indicate the need for aggressive management of patients at risk for device-related thrombosis. There were 74 incidences of DRT in 65 of the 1,739 Watchman […]
FDA taps Apple, J&J and others for health software pre-cert pilot
The FDA yesterday named the nine companies that will be included in a pilot program to pre-certify healthcare software developers. The program was designed with the hopes of reducing the amount of information the regulatory watchdog requires for review. The companies include Apple (NSDQ:AAPL), Fitbit (NYSE:FIT), Johnson & Johnson (NYSE:JNJ), Pear Therapeutics, Phosphorus, Roche (OTC:RHHBY), Samsung, Tidepool and Verily. […]
